Yaakov Stern1, Anna MacKay-Brandt2, Seonjoo Lee2, Paula McKinley2, Kathleen McIntyre2, Qolamreza Razlighi2, Emil Agarunov2, Matthew Bartels2, Richard P Sloan2. 1. From the Cognitive Neuroscience Division, Department of Neurology and Taub Institute (Y.S., A.M.-B., Q.R., E.A.), Department of Biostatistics (S.L.), and Department of Psychiatry, Division of Behavioral Medicine (P.M., K.M., R.P.S.), Columbia University, New York; Division of Clinical Research (A.M.-B.), Nathan Kline Institute for Psychiatric Research, Orangeburg; Division of Biostatistics (S.L.), New York State Psychiatric Institute; and Cardiopulmonary Rehabilitation and the Human Performance Laboratory (M.B.), Columbia Presbyterian Medical Center, New York, NY. ys11@columbia.edu. 2. From the Cognitive Neuroscience Division, Department of Neurology and Taub Institute (Y.S., A.M.-B., Q.R., E.A.), Department of Biostatistics (S.L.), and Department of Psychiatry, Division of Behavioral Medicine (P.M., K.M., R.P.S.), Columbia University, New York; Division of Clinical Research (A.M.-B.), Nathan Kline Institute for Psychiatric Research, Orangeburg; Division of Biostatistics (S.L.), New York State Psychiatric Institute; and Cardiopulmonary Rehabilitation and the Human Performance Laboratory (M.B.), Columbia Presbyterian Medical Center, New York, NY.
Abstract
OBJECTIVE: To determine efficacy of aerobic exercise for cognitive function in younger healthy adults. METHODS: In a randomized, parallel-group, observer-masked, community-based clinical trial, 132 cognitively normal individuals aged 20-67 with below median aerobic capacity were randomly assigned to one of two 6-month, 4-times-weekly conditions: aerobic exercise and stretching/toning. Efficacy measures included aerobic capacity; cognitive function in several domains (executive function, episodic memory, processing speed, language, and attention), everyday function, body mass index (BMI), and cortical thickness. RESULTS: Aerobic capacity increased significantly (β = 2.718; p = 0.003), and BMI decreased significantly (β = -0.596; p = 0.013) in the aerobic exercise but not in the stretching/toning condition. Executive function improved significantly in the aerobic exercise condition; this effect was moderated by age (β = 0.018 SD/y; p = 0.028). At age 40, the executive function measure increased by 0.228 SD (95% confidence interval [CI] 0.007-0.448), and by 0.596 SD (95% CI 0.219-0.973) at age 60. Cortical thickness increased significantly in the aerobic exercise group in a left frontal region and did not interact with age. Controlling for age and baseline performance, individuals with at least one APOE ε4 allele showed less improvement in executive function with aerobic exercise (β = 0.5129, 95% CI 0.0381-0.988; p = 0.0346). CONCLUSIONS: This randomized clinical trial demonstrates the efficacy of aerobic exercise for cognition in adults age 20-67. The effect of aerobic exercise on executive function was more pronounced as age increased, suggesting that it may mitigate age-related declines. Increased cortical thickness suggests that aerobic exercise contributes to brain health in individuals as young as age 20. CLINICALTRIALSGOV IDENTIFIER: NCT01179958. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that for adults age 20-67 with below median aerobic capacity, aerobic exercise significantly improves executive function but not other measures of cognitive function.
OBJECTIVE: To determine efficacy of aerobic exercise for cognitive function in younger healthy adults. METHODS: In a randomized, parallel-group, observer-masked, community-based clinical trial, 132 cognitively normal individuals aged 20-67 with below median aerobic capacity were randomly assigned to one of two 6-month, 4-times-weekly conditions: aerobic exercise and stretching/toning. Efficacy measures included aerobic capacity; cognitive function in several domains (executive function, episodic memory, processing speed, language, and attention), everyday function, body mass index (BMI), and cortical thickness. RESULTS: Aerobic capacity increased significantly (β = 2.718; p = 0.003), and BMI decreased significantly (β = -0.596; p = 0.013) in the aerobic exercise but not in the stretching/toning condition. Executive function improved significantly in the aerobic exercise condition; this effect was moderated by age (β = 0.018 SD/y; p = 0.028). At age 40, the executive function measure increased by 0.228 SD (95% confidence interval [CI] 0.007-0.448), and by 0.596 SD (95% CI 0.219-0.973) at age 60. Cortical thickness increased significantly in the aerobic exercise group in a left frontal region and did not interact with age. Controlling for age and baseline performance, individuals with at least one APOE ε4 allele showed less improvement in executive function with aerobic exercise (β = 0.5129, 95% CI 0.0381-0.988; p = 0.0346). CONCLUSIONS: This randomized clinical trial demonstrates the efficacy of aerobic exercise for cognition in adults age 20-67. The effect of aerobic exercise on executive function was more pronounced as age increased, suggesting that it may mitigate age-related declines. Increased cortical thickness suggests that aerobic exercise contributes to brain health in individuals as young as age 20. CLINICALTRIALSGOV IDENTIFIER: NCT01179958. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that for adults age 20-67 with below median aerobic capacity, aerobic exercise significantly improves executive function but not other measures of cognitive function.
Authors: Kristine B Walhovd; Andreas B Storsve; Lars T Westlye; Christian A Drevon; Anders M Fjell Journal: Neurobiol Aging Date: 2013-11-21 Impact factor: 4.673
Authors: Stanley J Colcombe; Kirk I Erickson; Naftali Raz; Andrew G Webb; Neal J Cohen; Edward McAuley; Arthur F Kramer Journal: J Gerontol A Biol Sci Med Sci Date: 2003-02 Impact factor: 6.053
Authors: Yen Ying Lim; Judith Jaeger; Karra Harrington; Tim Ashwood; Kathryn A Ellis; Albrecht Stöffler; Cassandra Szoeke; Rebecca Lachovitzki; Ralph N Martins; Victor L Villemagne; Ashley Bush; Colin L Masters; Christopher C Rowe; David Ames; David Darby; Paul Maruff Journal: Arch Clin Neuropsychol Date: 2013-04-03 Impact factor: 2.813
Authors: Jin San Lee; Hee Young Shin; Hee Jin Kim; Young Kyoung Jang; Na-Yeon Jung; Juyoun Lee; Yeo Jin Kim; Phillip Chun; Jin-Ju Yang; Jong-Min Lee; Mira Kang; Key-Chung Park; Duk L Na; Sang Won Seo Journal: Sci Rep Date: 2016-04-11 Impact factor: 4.379
Authors: Juan C Pedemonte; George S Plummer; Shubham Chamadia; Joseph J Locascio; Eunice Hahm; Breanna Ethridge; Jacob Gitlin; Reine Ibala; Jennifer Mekonnen; Katia M Colon; M Brandon Westover; David A D'Alessandro; George Tolis; Timothy Houle; Kenneth T Shelton; Jason Qu; Oluwaseun Akeju Journal: Anesthesiology Date: 2020-08 Impact factor: 7.892
Authors: James A Blumenthal; Patrick J Smith; Stephanie Mabe; Alan Hinderliter; Kathleen Welsh-Bohmer; Jeffrey N Browndyke; P Murali Doraiswamy; Pao-Hwa Lin; William E Kraus; James R Burke; Andrew Sherwood Journal: J Am Geriatr Soc Date: 2019-11-22 Impact factor: 5.562
Authors: Ronald M Lazar; Virginia J Howard; Walter N Kernan; Hugo J Aparicio; Deborah A Levine; Anthony J Viera; Lori C Jordan; David L Nyenhuis; Katherine L Possin; Farzaneh A Sorond; Carole L White Journal: Stroke Date: 2021-03-15 Impact factor: 7.914
Authors: Carolyn S Kaufman; Robyn A Honea; Joseph Pleen; Rebecca J Lepping; Amber Watts; Jill K Morris; Sandra A Billinger; Jeffrey M Burns; Eric D Vidoni Journal: J Cereb Blood Flow Metab Date: 2021-01-28 Impact factor: 6.200
Authors: R Boyle; S P Knight; C De Looze; D Carey; S Scarlett; Y Stern; I H Robertson; R A Kenny; R Whelan Journal: Alzheimers Res Ther Date: 2021-07-12 Impact factor: 6.982